2003;60:259-66.
213. Gray WA, Chaturvedi S, Verta P. Thirty-day outcomes for carotid
artery stenting in 6320 patients from 2 prospective, multicenter,
high-surgical-risk registries. Circ Cardiovasc Interv 2009;2:159-66.
214. Gray WA, Hopkins LN, Yadav S, Davis T, Wholey M, Atkinson R, et al.
Protected carotid stenting in high-surgical-risk patients: the
ARCHeR results. J Vasc Surg 2006;44:258-68.
215. Higashida RT, Popma JJ, Apruzzese P, Zimetbaum P. Evaluation of
the Medtronic exponent self-expanding carotid stent system with
the Medtronic guardwire temporary occlusion and aspiration system in the treatment of carotid stenosis: combined from the
MAVErIC (Medtronic AVE Self-expanding CaRotid Stent System
with distal protection In the treatment of Carotid stenosis) I and
MAVErIC II trials. Stroke 2010;41:e102-9.
216. Zarins CK, White RA, Diethrich EB, Shackelton RJ, Siami FS. Carotid
revascularization using endarterectomy or stenting systems
(CaRESS): 4-year outcomes. J Endovasc Ther 2009;16:397-409.
217. LoGerfo FW. Carotid stents: unleashed, unproven. Circulation
2007;116:1596-601; discussion: 601.
218. Naylor AR, Bell PR. Treatment of asymptomatic carotid disease with
stenting: con. Semin Vasc Surg 2008;21:100-7.
219. Brott TG, Halperin JL, Abbara S, Bacharach JM, Barr JD, Bush RL,
et al. 2011 ASA/ACCF/AHA/AANN/AANS/